Of note, mutations within the HLA class I alleles, mostly in HLA-A and HLA-C (Supplementary Table 2), were identified in the tumour lesion obtained from patient PanTT39, which may have given rise to preferential expansion of CD4+ T cells recognising the nominal tumour target antigen bound to HLA class II molecules. The gene discussed is HLA-A; the disease is neoplasm.